Maylis Coste

Subgroup Analyses in Randomized Clinical Trials: Statistical and Regulatory Issues

John A. Lewis, Jean-Marie Grouin, Maylis Coste, 2005, Journal of biopharmaceutical statistics.

Re: Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France.

N. Deltour, Maylis Coste, I. Tupinon-Mathieu, 2012, Pharmacoepidemiology and drug safety.

Letter to the Editor

N. Deltour, Maylis Coste, I. Tupinon-Mathieu, 2012, Pharmacoepidemiology and Drug Safety.

Logistic regression model of fotemustine toxicity combining independent phase II studies

E. Raymond, C. Haon, Maylis Coste, 1996, Cancer.

Bayesian sample size determination in non‐sequential clinical trials: Statistical aspects and some regulatory considerations

Bruno Lecoutre, Jean-Marie Grouin, Maylis Coste, 2007, Statistics in medicine.